An essential aspect of ensuring a successful product development and launch strategy
The pharmaceutical and biotechnology industries are constantly faced with the challenge of delivering effective treatments to the appropriate patients at an affordable cost. To achieve this goal, it is crucial to approach the market with a well-rounded strategy that encompasses three key factors: effectively communicating the benefits of the product, understanding the needs of payers, and utilizing solution-focused communication. This can be achieved through a market access strategy that consists of four interconnected steps, providing a clear path to success.
Define market access strategy
We place a high value on timing, recognizing the critical role it plays in the development of trial design, HEOR, and RWE studies. Our belief is that these elements should be strategized in the early stages of a product's clinical development.
Know the market
There are noteworthy variations in processes and regulations among countries. Therefore, we carefully examine the unique access pathways, as well as the diverse HTA and P&R procedures, taking into consideration the relevant levels of evidence, crucial decision factors, and the various stakeholders (such as HTA and P&R bodies, key opinion leaders, and patient representatives) involved in the decision-making process. This enables us to effectively target each market accordingly, promoting fluency and engagement in our approach.
Economic model
Our skill and knowledge allow us to craft a comprehensive global value dossier, including strong evidence from clinical trials (demonstrating efficacy and safety) and societal factors (such as quality of life and economic impact). This dossier will be presented to the relevant authorities for evaluation. Typically, our economic model will consist of either a budget impact analysis or a cost-effectiveness analysis, with a focus on the quality of life outcomes. Our goal is to engage and persuade decision-makers of the value of the product.
Negotiations
Before entering the market, the final crucial stage involves negotiating pricing and reimbursement with the agencies. Our suggestion is to adopt solution-oriented communication, which allows for clear and direct transmission of core messages, as well as effective responses to unforeseen counter-arguments. This approach will ensure strong engagement and fluency in your communications.
"Romeo Life Sciences stands out as an exceptional partner, well-equipped to assist pharmaceutical companies with the crucial steps involved in market access."
Get in touch
Fill out the Request for Information and we will connect you to our experts
